Abstract
The notion that oxidation of lipids and propagation of free radicals may contribute to the pathogenesis of atherosclerosis is supported by a large body of evidence. To circumvent the damage caused by oxygen free radicals, antioxidants are needed which provide the much needed neutralization of free radical by allowing the pairing of electrons. In this study we have investigated the effect of ascorbic acid, a water soluble antioxidant on the development of hypercholesterolemia induced atherosclerosis in rabbits. Rabbits were made hypercholesterolemic and atherosclerotic by feeding 100 mg cholesterol/day. Different doses of ascorbic acid were administered to these rabbits. Low dose of ascorbic acid (0.5 mg/100 g body weight/day) did not have any significant effect on the percent of total area covered by atherosclerotic plaque. However, ascorbic acid when fed at a higher dose (15 mg/100 g body weight/day) was highly effective in reducing the atherogenecity. With this dose the percent of total surface area covered by atherosclerotic plaque was significantly less (p < 0.001). This suggests that use of ascorbic acid may have great promise in the prevention of hypercholesterolemia induced atherosclerosis.
Similar content being viewed by others
References
Watanabe T, Pakala R, Katagiri T, Benedict CR: Lipid peroxidation product 4-hydroxy-2 nonenal acts synergistically with serotinin in inducing vascular smooth muscle cell proliferation. Atherosclerosis 155: 37–44, 2001.
Stamler J, Wentworth D, Neaton JD: Is relationship between serum cholesterol and Risk of premature death from coronary heart disease continuous and grades. JAMA 256: 2823–2828, 1986.
Lipid Research Clinics program: The Lipid Research Clinics coronary primary prevention trial results: I. Reduction in the incidence of coronary heart disease. JAMA 251 351–364, 1984.
Lipid Research Clinic Program: The Lipid Research Clinics coronary primary prevention trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365–374, 1984.
Blankenhorn DM, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, CashinHemphill L: Beneficial effects of combined colestipol – niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257: 3233–3240, 1987.
Brown G, Albers JJ: Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323: 1289–1298, 1990.
Buchwald H, Varco RL, Matts JP: Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the program on the surgical control of Hyperlipidemias (POSCH). N Engl J Med 323: 946–955, 1990.
Nikkila EA, Taskinen MR, Rehunen S, Harkonen M: Lipoprotein lipase activity in adipose tissue and skeletal muscle of runners: Relation to serum lipoproteins. Metabolism 27: 1661–1671, 1978.
Witzhum JL: The oxidation hypothesis of atherosclerosis. Lancet 344: 793–795, 1994.
Duthie GG, Wahle KWJ, James WPT: Oxidants and antioxidants and cardiovascular disease. Nutr Res Rev 2: 51–62, 1989.
Carroll KK, Khor HT: Effects of level and type of dietary fat on incidence of mammary tumors induced in female Sprague-Dawley rats by 7,12 dimethylbenz (alpha) anthracene. Lipids 6: 415–420, 1971.
Rosenfeld ME, Tsukada T, Gown AM, Ross R: Fatty streak initiation in watanabe heritable hyperlipidemic and comparable hypercholesterolemic fat fed rabbits. Arteriosclerosis 7: 9–23, 1987.
Rosenfeld ME, Tsukada T, Chait A, Biermann EL, Gown AM, Ross R: Fatty streak expansion and maturation in watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat fed rabbits. Arteriosclerosis 7: 24–34, 1987.
Gerrity RG, Naito HK, Richardson M, Schwartz CJ: Dietary induced atherogenesis in Swine. Am J Pathol 95: 775–792, 1979.
Faggioto A, Ross R: Studies of hypercholesterolemia in non human primates. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4: 341–356, 1984.
Masuda J, Ross R: Atherogenesis during low level of hypercholesterolemia in the non human primate. I. Fatty streak formation. Arteriosclerosis 10: 164–177, 1990.
Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: Apo E deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14: 133–140, 1994.
Das S, Lata S, Srivastava LM: Effect of ascorbic acidon lipid profile and lipid peroxidation in hypercholesterolemic rabbits. Nutr Res 17: 231–241, 1997.
Prasad K, Kalra J: Oxygen free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125: 958–973, 1993.
Mehmetcik G, Toker G, Uysal M:Endogenous and copper induced lipid peroxidation and antioxidant activity of serum in hypercholesterolemic subjects. Horm Metab Res 29: 63–65, 1997.
Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenecity. N Engl J Med 320: 915–924, 1989.
Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidant in vivo can selectively inhibit low density lipoprotein degradation in macrophage rich fatty streaks and slow the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 84: 7725–7729, 1987.
Rodriguez JA, Nespereira B, Perez-Ilzarbe M, Eguinoa E, Paramo JA: Vitamins C and E prevent endothelial VEGF and VEGFR-2 over expression induced by porcine hypercholesterolemic LDL. Cardiovasc Res 65: 665–673, 2005.
Roland Stocker, John F Keany Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1382–1478, 2004.
Behzad Molavi and Jawahar L Mehta : Oxidative stress in cardiovascular disease: molecular basis of its deleterios effects, its detection and therapeutic considerations. Current opinion in Cardiology 19: 488–493, 2004.
Viswanathan NM, Bhakthan NMG, Rockerbie RA: Effect of dietary supplementation of vitamin E on serum lipids and lipoproteins in rabbits fed a cholesterolemic diet. Int J Vitamin Res 49: 370–375, 1979.
Wojcicki J, Samochowice L, Jaworska M, Hinek A: A search for a model of experimental atherosclerosis: comparative studies in rabbits, guinea pigs and rats. Pol J Pharmacol Pharm 37: 11–21, 1985.
Sugano M, Nakashima Y, Tasaki H, Takasugi M, Kuroiwa A, Koide O: Effects of diltiazem on suppression and regression of experimental atherosclerosis. Br J Exp Pathol 69: 515–523, 1988.
Ohara Y, Peterson TE, Harrison DG: Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91: 2546–2551, 1993.
Steinberg D: Antioxidants and atherosclerosis. A current assessment. Circulation 84: 1420–1425, 1991.
Parthasarathy S, Steinberg D, Witztum JL: The role of oxidized low density lipoproteins in the pathogenesis of atherosclerosis. Ann Rev Med 43: 219–225, 1992.
Steinberg D: Antioxidants in the prevention of human atherosclerosis. Circulation 85: 2338–2345, 1992.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Das, S., Ray, R., Snehlata et al. Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis. Mol Cell Biochem 285, 143–147 (2006). https://doi.org/10.1007/s11010-005-9070-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-9070-x